Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Over a decade of in-vitro data support a critical role for members of the Homer family of postsynaptic scaffolding proteins in regulating the functional architecture of glutamate synapses. Earlier studies of Homer knockout mice indicated a necessary role for Homer gene products in normal mesocorticolimbic glutamate transmission and behaviours associated therewith. The advent of adeno-associated viral vectors carrying cDNA for, or short hairpin RNA against, specific Homer isoforms enabled the site-directed targeting of Homers to neurons in the brain. This approach has allowed our groups to address developmental issues associated with conventional knockout mice, to confirm active roles for distinct Homer isoforms in regulating glutamate transmission in vivo, as well as in mediating a variety of behavioural processes. This review summarizes the existing data derived from our studies using adeno-associated viral vector-mediated neuronal targeting of Homer in rodents, implicating this family of proteins in drug and alcohol addiction, learning/memory and emotional processing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009 · cited 5×
“…1998; Roche et al., 1999; Ango et al., 2000; Soloviev et al., 2000), the N-methyl-D-aspartate (NMDA) glutamate receptor scaffolding protein Shank (Naisbitt et al., 1999; Tu et al., 1999; Shiraishi et al., 2003), the inositol-1,4,5-triphosphate (IP3) receptor, a downstream mediator of group 1…”
BackgroundInfluentialTu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · cited 11×
“Homers also interact with a proline-rich sequence located on IP3Rs (Tu et al., 1998) and form mGluR/Homer/IP3R clusters in the perisynapse (Tu et al., 1998; Sala et al., 2005).”
BackgroundInfluentialBurger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741
Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer
Sala, C., Piëch, V., Wilson, N. R., Passafaro, M., Liu, G., & Sheng, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00339-7 · Cited by 716
The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus
Monory, K., Massa, F., Egertová, M., Eder, M., Blaudzun, H., Westenbroek, R., Kelsch, W., Jacob, W., Marsch, R., Ekker, M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.006 · Cited by 706
Self-citationPsychomotor stimulant addiction: a neural systems perspective
Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission
Kalivas, P. W., Volkow, N., & Seamans, J. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.005 · Cited by 657
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583 · cited 1×
“The choice of promoter often depends upon a compromise between the levels of expression required, the target cell type and the size of the promoter that can be accommodated by the cassette without overstretching the 4.7-kb AAV packaging limit (Dong et al., 1996).”
BackgroundInfluentialSamulski, R. J., Berns, K. I., Tan, M., & Muzyczka, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2077 · Cited by 466 · cited 1×
“AAV serotype 2 (AAV2) was the first infectious clone established in the laboratory (Samulski et al., 1982), which made this serotype the best studied and the most commonly used one to date.”
BackgroundHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443 · cited 2×
“AAV2 (Summerford and Samulski, 1998), whereas human fibroblast growth factor receptor 1 (Qing et al., 1999), aVb5 integrin (Summerford et al.”
Background
Cited by
Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving
Loweth, J. A., Scheyer, A. F., Milovanovic, M., LaCrosse, A. L., Flores-Barrera, E., Werner, C. T., Li, X., Ford, K. A., Le, T., Olive, M. F., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3590 · Cited by 157
Self-citationBell, R. L., Hauser, S. R., McClintick, J., Rahman, S., Edenberg, H. J., Szumlinski, K. K., & McBride, W. J. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.018 · Cited by 65
Self-citationKlugmann, M., Goepfrich, A., Friemel, C. M., & Schneider, M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00037 · Cited by 49
Self-citationKlugmann, M., Klippenstein, V., Leweke, F. M., Spanagel, R., & Schneider, M. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001562 · Cited by 38
Self-citationde Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21
Metadata
- Authors
- Klugmann, M., & Szumlinski, K. K.
- Venue
- Behavioural Pharmacology
- Published
- 2008-09
- Volume
- 19
- Issue
- 5-6
- Pages
- 485-500
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2000850951
- Cited by
- 33
- References
- 23
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.